TabletsClinical Overview
Etizolam and Propranolol is a psychotropic and autonomic regulator combination pairing a thienodiazepine with a non-selective beta-blocker. Etizolam acts as a full agonist at central GABAA receptors to suppress emotional distress and anticipatory anxiety, while propranolol blocks peripheral beta-adrenergic receptors to eliminate somatic symptoms (tachycardia, palpitations, sweating, tremors). Indicated for situational anxiety, autonomic anxiety manifestations, panic disorder, and tension headache.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Swallow whole with water, with or without food. Use on a short-term basis as directed. Do not stop abruptly; taper slowly under medical supervision.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness, fatigue, bradycardia, dizziness, muscle relaxation, cold extremities. Rare/Severe: Severe respiratory depression, bronchospasm, dependence, and rebound anxiety.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contraindicated in asthma, severe sinus bradycardia, heart block, and myasthenia gravis. High habit-forming and dependence risk. Avoid alcohol.
Schedule H1 (Prescription Required - Habit Forming Warning)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.
Propranolol Tablets 40 mg
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Etizolam Tablets 0.5mg
Etizolam is a thienodiazepine derivative structurally related to benzodiazepines. It acts as a potent full agonist at the GABAA receptor, producing significant anxiolytic, sedative-hypnotic, anticonvulsant, and muscle-relaxant actions with 6- to 10-fold higher potency than diazepam. Indicated for short-term management of generalized anxiety disorder, panic disorder, and insomnia associated with anxiety.
Propranolol Tablets 10mg
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Alprazolam 0.25mg + Propranolol Hydrochloride 20mg Tablets
Alprazolam and Propranolol Hydrochloride is a synergistic psychotropic-cardiovascular formulation combining a triazolobenzodiazepine with a non-selective beta-adrenergic blocker. Alprazolam enhances central inhibitory GABAergic neurotransmission at the GABAA receptor, relieving psychological panic and tension, while propranolol competitively antagonizes peripheral beta-1 and beta-2 adrenergic receptors, curbing somatic autonomic manifestations of anxiety (palpitations, resting tachycardia, tremors, sweating). Indicated for situational anxiety, panic disorder with severe autonomic hyperactivity, and performance anxiety.